The Department of Radiation Oncology and our faculty are involved with numerous active clinical trials as sponsors and collaborators. Our current active studies are listed below. If you have any questions about the particular study, please contact the study coordinator.
Feinberg Clinical Trials
Scientists at the medical school are conducting hundreds of clinical trials daily. Learn more about all our work via the Feinberg Office of Research Clinical Trials page. Search for trials by disease or condition.
Clinical Research Office
Find more about the clinical research done within the Robert H. Lurie Comprehensive Cancer Center through the Clinical Research Office.
|Gianna Mirabelli||Bharat Mittal, MD||A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer (RTOG 0920)|
|Gianna Mirabelli||Sean Sachdev, MD||Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma (NRG BN003)|
|Gianna Mirabelli||Eric Donnelly, MD||A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy (RTOG 1304)|
|Gianna Mirabelli||Eric Donnelly, MD||Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-Risk Patients with Early-Stage Cervical Carcinoma Following Radical Hysterectomy (RTOG 0724)|
|Gianna Mirabelli||John Hayes, MD||A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer (NRG GI002)|
|Gianna Mirabelli||Timothy Kruser, MD||Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy with or without Hippocampal Avoidance In Patients with Brain Metastases (NRG CC001)|
|Gianna Mirabelli||John Hayes, MD||A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma (RTOG 0848)|
|Gianna Mirabelli||Jonathan Strauss, MD|
A Phase IIR/III Trial of Standard of Care Therapy with or without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer (NRG BR002)
|Gianna Mirabelli||John Hayes, MD||Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma (NRG GI001)|
|Gianna Mirabelli||Sean Sachdev, MD||Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxelses (NRG GU002)|
|Gianna Mirabelli||Bharat Mittal, MD||Randomized Phase II And Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA) (NRG HN001)|